---
figid: PMC6266939__cancers-10-00422-g001
figlink: /pmc/articles/PMC6266939/figure/cancers-10-00422-f001/
number: F1
caption: 'Main components of the Hippo pathway and the current Hippo-targeted inhibitors
  discussed in this review. In mammals, the canonical Hippo pathway consists of four
  core components that function through phosphorylation: MST, SAV1, LATS, MOB1. Activated
  LATS phosphorylates YAP/TAZ, preventing them from entering the nucleus by anchoring
  them to 14-3-3 protein and/or promoting their degradation in the cytoplasm. This
  interrupts their interactions with the transcription factor TEAD family proteins,
  which subsequently inhibits cell proliferation and oncogenic transformation and
  induces apoptosis. Besides, current Hippo-targeted inhibitors discussed in this
  review, as well as their targets and major mechanisms, are shown in the figure.'
pmcid: PMC6266939
papertitle: Targeting the Hippo Pathway for Breast Cancer Therapy.
reftext: Liqing Wu, et al. Cancers (Basel). 2018 Nov;10(11):422.
pmc_ranked_result_index: '92204'
pathway_score: 0.9411814
filename: cancers-10-00422-g001.jpg
figtitle: Main components of the Hippo pathway and the current Hippo-targeted inhibitors
  discussed in this review
year: '2018'
organisms:
- Mus musculus
- Lareunionomyces loeiensis
- Drosophila melanogaster
- Homo sapiens
ndex: f648a2c8-df04-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6266939__cancers-10-00422-g001.html
  '@type': Dataset
  description: 'Main components of the Hippo pathway and the current Hippo-targeted
    inhibitors discussed in this review. In mammals, the canonical Hippo pathway consists
    of four core components that function through phosphorylation: MST, SAV1, LATS,
    MOB1. Activated LATS phosphorylates YAP/TAZ, preventing them from entering the
    nucleus by anchoring them to 14-3-3 protein and/or promoting their degradation
    in the cytoplasm. This interrupts their interactions with the transcription factor
    TEAD family proteins, which subsequently inhibits cell proliferation and oncogenic
    transformation and induces apoptosis. Besides, current Hippo-targeted inhibitors
    discussed in this review, as well as their targets and major mechanisms, are shown
    in the figure.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAA2
  - SAV1
  - PRKAB1
  - PRKAB2
  - PRKAG2
  - YWHAQ
  - RAF1
  - BRAF
  - RHOD
  - PRKAG3
  - PRKAG1
  - CDK1
  - ILK
  - ROCK1
  - CXCL10
  - AMOT
  - PRKAA1
  - PLD2
  - ARAF
  - PLD1
  - PLD4
  - PLD5
  - PLD6
  - ROCK2
  - YY1AP1
  - PLD3
  - TAZ
  - H
  - QLT0267
  - Y27632
  - CAY10594
  - Dasatinib
  - Metformin
  - Auranofin
  - Pazopanib
  - BAY1238097
  - Verteporfin
genes:
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: SAV1
  symbol: SAV1
  source: hgnc_symbol
  hgnc_symbol: SAV1
  entrez: '60485'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: 14-3-3
  symbol: 14-3-3
  source: hgnc_alias_symbol
  hgnc_symbol: YWHAQ
  entrez: '10971'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Rho
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: CDK1
  symbol: CDK1
  source: hgnc_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: ILK
  symbol: ILK
  source: hgnc_symbol
  hgnc_symbol: ILK
  entrez: '3611'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
- word: MOB1
  symbol: mob-1
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: AMOT
  symbol: AMOT
  source: hgnc_symbol
  hgnc_symbol: AMOT
  entrez: '154796'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD2
  entrez: '5338'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD1
  entrez: '5337'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD4
  entrez: '122618'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD5
  entrez: '200150'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD6
  entrez: '201164'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
- word: YAP/TAZ
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD3
  entrez: '23646'
- word: YAP/TAZ
  symbol: TAZ
  source: hgnc_symbol
  hgnc_symbol: TAZ
  entrez: '6901'
chemicals:
- word: H
  source: MESH
  identifier: D006859
- word: QLT0267
  source: MESH
  identifier: C552362
- word: Y27632
  source: MESH
  identifier: C108830
- word: CAY10594
  source: MESH
  identifier: C472966
- word: Dasatinib
  source: MESH
  identifier: C488369
- word: Metformin
  source: MESH
  identifier: D008687
- word: Auranofin
  source: MESH
  identifier: D001310
- word: Pazopanib
  source: MESH
  identifier: C516667
- word: BAY1238097
  source: MESH
  identifier: C434003
- word: Verteporfin
  source: MESH
  identifier: C098350
diseases: []
figid_alias: PMC6266939__F1
redirect_from: /figures/PMC6266939__F1
figtype: Figure
---
